Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEN and Azathioprine for Postoperative Crohn's Disease
NCT04160325Unknown
- Sponsor
- Weiming Biopharma
- Start
- Jan 2018
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in Crohn's disease (2 arms), sponsored by Weiming Biopharma. Primary endpoint: 1 year postoperative anastomotic recurrence. Status: unknown.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04160325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160325.